Tevogen Bio Holdings Signs Letter Of Intent To Evaluate Potential Acquisition Of Apozeal Pharmaceutical
Benzinga Newsdesk 8 months ago
M&A
If consummated, the potential acquisition of Apozeal could provide Tevogen with an established generics platform, including:11 FDA-approved Abbreviated New Drug Application (ANDA) products for the U.S. marketMultiple
If consummated, the potential acquisition of Apozeal could provide Tevogen with an established generics platform, including:
- 11 FDA-approved Abbreviated New Drug Application (ANDA) products for the U.S. market
- Multiple ANDAs currently filed with the U.S. Food and Drug Administration awaiting approval
- Additional generic products in development